Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) COO Sells $770,339.40 in Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 5,556 shares of ICU Medical stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $138.65, for a total transaction of $770,339.40. Following the sale, the chief operating officer now owns 2,389 shares in the company, valued at approximately $331,234.85. This represents a 69.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

ICU Medical Trading Up 0.6%

NASDAQ:ICUI opened at $141.38 on Friday. ICU Medical, Inc. has a 52 week low of $100.91 and a 52 week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The firm’s fifty day moving average is $140.85 and its 200-day moving average is $153.95. The firm has a market cap of $3.48 billion, a P/E ratio of -30.94 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.49. The business had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. ICU Medical’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.96 earnings per share. Equities analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in ICUI. Barclays PLC grew its stake in ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after purchasing an additional 8,010 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after buying an additional 25,031 shares in the last quarter. Vanguard Group Inc. grew its position in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock worth $416,176,000 after buying an additional 17,805 shares during the period. Jennison Associates LLC bought a new stake in shares of ICU Medical in the 4th quarter valued at $556,000. Finally, Franklin Resources Inc. increased its stake in shares of ICU Medical by 99.3% in the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock valued at $2,111,000 after acquiring an additional 5,834 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Sunday. KeyCorp cut their target price on ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Finally, Raymond James decreased their price target on ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a research note on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $192.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.